{"OMIM ID": "OMIM:615473", "DISEASE": "Epileptic Encephalopathy, Early Infantile, 17", "RECORD": "Rare disease patients have complex clinical representations. Patients with Epileptic Encephalopathy, Early Infantile, 17 present clinical features that include epileptic seizures, developmental delay, motor and speech delay, and autism spectrum disorder. In addition, the patients may present with ataxia, hypotonia, dysmorphic features, and/or a distinctive facial appearance.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat. Some special cases also present with ataxia, hypotonia, dysmorphic features, and/or a distinctive facial appearance.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a. The main symptomatic differences of Epileptic Encephalopathy, Early Infantile, 17 from similar diseases is that the patients present with ataxia, hypotonia, dysmorphic features, and/or a distinctive facial appearance.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.", "SUMMARY": "\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of small molecule therapeutics that are designed to treat.\n\nThe company is developing a proprietary pipeline of"}